211 related articles for article (PubMed ID: 26659129)
1. A recessive Nav1.4 mutation underlies congenital myasthenic syndrome with periodic paralysis.
Habbout K; Poulin H; Rivier F; Giuliano S; Sternberg D; Fontaine B; Eymard B; Morales RJ; Echenne B; King L; Hanna MG; Männikkö R; Chahine M; Nicole S; Bendahhou S
Neurology; 2016 Jan; 86(2):161-9. PubMed ID: 26659129
[TBL] [Abstract][Full Text] [Related]
2. Myasthenic congenital myopathy from recessive mutations at a single residue in Na
Elia N; Palmio J; Castañeda MS; Shieh PB; Quinonez M; Suominen T; Hanna MG; Männikkö R; Udd B; Cannon SC
Neurology; 2019 Mar; 92(13):e1405-e1415. PubMed ID: 30824560
[TBL] [Abstract][Full Text] [Related]
3. Defective fast inactivation recovery of Nav 1.4 in congenital myasthenic syndrome.
Arnold WD; Feldman DH; Ramirez S; He L; Kassar D; Quick A; Klassen TL; Lara M; Nguyen J; Kissel JT; Lossin C; Maselli RA
Ann Neurol; 2015 May; 77(5):840-50. PubMed ID: 25707578
[TBL] [Abstract][Full Text] [Related]
4. Loss-of-function mutations in SCN4A cause severe foetal hypokinesia or 'classical' congenital myopathy.
Zaharieva IT; Thor MG; Oates EC; van Karnebeek C; Hendson G; Blom E; Witting N; Rasmussen M; Gabbett MT; Ravenscroft G; Sframeli M; Suetterlin K; Sarkozy A; D'Argenzio L; Hartley L; Matthews E; Pitt M; Vissing J; Ballegaard M; Krarup C; Slørdahl A; Halvorsen H; Ye XC; Zhang LH; Løkken N; Werlauff U; Abdelsayed M; Davis MR; Feng L; Phadke R; Sewry CA; Morgan JE; Laing NG; Vallance H; Ruben P; Hanna MG; Lewis S; Kamsteeg EJ; Männikkö R; Muntoni F
Brain; 2016 Mar; 139(Pt 3):674-91. PubMed ID: 26700687
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological-genetic features of congenital myasthenic syndrome from a Chinese neuromuscular centre.
Huang K; Duan HQ; Li QX; Luo YB; Bi FF; Yang H
J Cell Mol Med; 2022 Jul; 26(14):3828-3836. PubMed ID: 35670010
[TBL] [Abstract][Full Text] [Related]
6. Normokalemic periodic paralysis is not a distinct disease.
Song YW; Kim SJ; Heo TH; Kim MH; Kim JB
Muscle Nerve; 2012 Dec; 46(6):914-6. PubMed ID: 22926674
[TBL] [Abstract][Full Text] [Related]
7. Activation and inactivation of the voltage-gated sodium channel: role of segment S5 revealed by a novel hyperkalaemic periodic paralysis mutation.
Bendahhou S; Cummins TR; Tawil R; Waxman SG; Ptácek LJ
J Neurosci; 1999 Jun; 19(12):4762-71. PubMed ID: 10366610
[TBL] [Abstract][Full Text] [Related]
8. Homozygous C-terminal loss-of-function Na
Echaniz-Laguna A; Biancalana V; Nadaj-Pakleza A; Fournier E; Matthews E; Hanna MG; Männikkö R
J Neurol Neurosurg Psychiatry; 2020 Aug; 91(8):898-900. PubMed ID: 32487525
[No Abstract] [Full Text] [Related]
9. Mice with an NaV1.4 sodium channel null allele have latent myasthenia, without susceptibility to periodic paralysis.
Wu F; Mi W; Fu Y; Struyk A; Cannon SC
Brain; 2016 Jun; 139(Pt 6):1688-99. PubMed ID: 27048647
[TBL] [Abstract][Full Text] [Related]
10. Novel mutations in human and mouse SCN4A implicate AMPK in myotonia and periodic paralysis.
Corrochano S; Männikkö R; Joyce PI; McGoldrick P; Wettstein J; Lassi G; Raja Rayan DL; Blanco G; Quinn C; Liavas A; Lionikas A; Amior N; Dick J; Healy EG; Stewart M; Carter S; Hutchinson M; Bentley L; Fratta P; Cortese A; Cox R; Brown SD; Tucci V; Wackerhage H; Amato AA; Greensmith L; Koltzenburg M; Hanna MG; Acevedo-Arozena A
Brain; 2014 Dec; 137(Pt 12):3171-85. PubMed ID: 25348630
[TBL] [Abstract][Full Text] [Related]
11. Hyperkalemic periodic paralysis associated with a novel missense variant located in the inner pore of Nav1.4.
Segawa K; Nishiyama M; Mori I; Kubota T; Takahashi MP
Brain Dev; 2023 Apr; 45(4):205-211. PubMed ID: 36628799
[TBL] [Abstract][Full Text] [Related]
12. Effects of S906T polymorphism on the severity of a novel borderline mutation I692M in Na
Fan C; Mao N; Lehmann-Horn F; Bürmann J; Jurkat-Rott K
Clin Genet; 2017 Jun; 91(6):859-867. PubMed ID: 27714768
[TBL] [Abstract][Full Text] [Related]
13. [Clinical and molecular genetic analysis of a family with normokalemic periodic paralysis].
Wei CJ; Wang D; Wang S; Jiao H; Hong DJ; Pu LH; Xiong H
Zhonghua Er Ke Za Zhi; 2013 Jan; 51(1):47-51. PubMed ID: 23527931
[TBL] [Abstract][Full Text] [Related]
14. Myasthenic syndrome caused by mutation of the SCN4A sodium channel.
Tsujino A; Maertens C; Ohno K; Shen XM; Fukuda T; Harper CM; Cannon SC; Engel AG
Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7377-82. PubMed ID: 12766226
[TBL] [Abstract][Full Text] [Related]
15. Novel delta subunit mutation in slow-channel syndrome causes severe weakness by novel mechanisms.
Gomez CM; Maselli RA; Vohra BP; Navedo M; Stiles JR; Charnet P; Schott K; Rojas L; Keesey J; Verity A; Wollmann RW; Lasalde-Dominicci J
Ann Neurol; 2002 Jan; 51(1):102-12. PubMed ID: 11782989
[TBL] [Abstract][Full Text] [Related]
16. A204E mutation in Na
Kokunai Y; Dalle C; Vicart S; Sternberg D; Pouliot V; Bendahhou S; Fournier E; Chahine M; Fontaine B; Nicole S
Sci Rep; 2018 Nov; 8(1):16681. PubMed ID: 30420713
[TBL] [Abstract][Full Text] [Related]
17. Hypokalaemic periodic paralysis and myotonia in a patient with homozygous mutation p.R1451L in Na
Luo S; Sampedro Castañeda M; Matthews E; Sud R; Hanna MG; Sun J; Song J; Lu J; Qiao K; Zhao C; Männikkö R
Sci Rep; 2018 Jun; 8(1):9714. PubMed ID: 29946067
[TBL] [Abstract][Full Text] [Related]
18. Enhanced slow inactivation of the human skeletal muscle sodium channel causing normokalemic periodic paralysis.
Wu L; Zhang B; Kang Y; Wu W
Cell Mol Neurobiol; 2014 Jul; 34(5):707-14. PubMed ID: 24682880
[TBL] [Abstract][Full Text] [Related]
19. [Congenital myasthenic syndromes: phenotypic expression and pathophysiological characterisation].
Andreux F; Hantaï D; Eymard B
Rev Neurol (Paris); 2004 Feb; 160(2):163-76. PubMed ID: 15034473
[TBL] [Abstract][Full Text] [Related]
20. New Challenges Resulting From the Loss of Function of Na
Nicole S; Lory P
Front Pharmacol; 2021; 12():751095. PubMed ID: 34671263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
